Vanguard Group
NMTR

Vanguard Group’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-619,829
Closed -$417K 4622
2023
Q2
$417K Sell
619,829
-8,477
-1% -$5.7K ﹤0.01% 4168
2023
Q1
$873K Hold
628,306
﹤0.01% 3958
2022
Q4
$792K Sell
628,306
-11,932,703
-95% -$15M ﹤0.01% 3982
2022
Q3
$2.7M Buy
12,561,009
+1,058,780
+9% +$228K ﹤0.01% 3618
2022
Q2
$3M Sell
11,502,229
-195,889
-2% -$51.1K ﹤0.01% 3627
2022
Q1
$7.01M Sell
11,698,118
-146,366
-1% -$87.7K ﹤0.01% 3343
2021
Q4
$11.6M Buy
11,844,484
+174,816
+1% +$171K ﹤0.01% 3135
2021
Q3
$15.2M Buy
11,669,668
+743,781
+7% +$967K ﹤0.01% 3009
2021
Q2
$12M Buy
10,925,887
+1,936,790
+22% +$2.13M ﹤0.01% 3117
2021
Q1
$10.5M Buy
8,989,097
+1,796,527
+25% +$2.1M ﹤0.01% 3114
2020
Q4
$6.18M Buy
7,192,570
+6,426,929
+839% +$5.52M ﹤0.01% 3258
2020
Q3
$624K Buy
765,641
+50,458
+7% +$41.1K ﹤0.01% 3769
2020
Q2
$410K Sell
715,183
-5,863
-0.8% -$3.36K ﹤0.01% 3813
2020
Q1
$363K Hold
721,046
﹤0.01% 3738
2019
Q4
$402K Sell
721,046
-9,084
-1% -$5.07K ﹤0.01% 3835
2019
Q3
$781K Sell
730,130
-225,014
-24% -$241K ﹤0.01% 3712
2019
Q2
$1.11M Buy
955,144
+121,104
+15% +$140K ﹤0.01% 3645
2019
Q1
$1.61M Buy
834,040
+313,086
+60% +$604K ﹤0.01% 3513
2018
Q4
$1.2M Buy
520,954
+196,639
+61% +$454K ﹤0.01% 3511
2018
Q3
$2.22M Buy
324,315
+257,730
+387% +$1.76M ﹤0.01% 3492
2018
Q2
$1.57M Buy
+66,585
New +$1.57M ﹤0.01% 3564
2017
Q4
Sell
-39,378
Closed -$28K 4081
2017
Q3
$28K Buy
39,378
+1,900
+5% +$1.35K ﹤0.01% 4047
2017
Q2
$18K Sell
37,478
-1,725
-4% -$828 ﹤0.01% 4063
2017
Q1
$47K Buy
+39,203
New +$47K ﹤0.01% 4029